Clinical and Economic Research

3M Health Information Systems

Tag: DRGs

DRGs (Diagnosis Related Groups) is a methodology for classifying patients based on the amount and type of hospital resources needed to treat them. Countries use DRGs or similar classification systems to allocate scarce resources, to determine reimbursement and funding and to measure the quality of care provided by hospitals. DRGs link clinical and financial data, and provide an operational means to define case mix (the range and type of patients a hospital treats). Most developed nations have adopted classification systems as the basis of their payment and quality measurement; many of these methodologies, including DRGs, were developed by 3M. The use of DRGs requires diagnosis and procedure coding, both primary businesses of 3M. This is an example of a language that enables communication across all entities involved in the delivery of healthcare.

3M Commentary

Where we’ve been and where we’re going: A 50-year perspective on health policy

By Megan Carr, Chet Stroyny

I recently had the opportunity to talk with Chet Stroyny, a program manager for Regulatory and Government Affairs at 3M…

3M Commentary

Payment and quality reform for mental health and substance abuse care: The time is now (part 2)

By Dawn Weimar, RN

In my last blog, I discussed mental health and substance abuse (MHSA) payment and quality in the midst of…

3M Commentary

Payment and quality reform for mental health and substance abuse care: The time is now

By Dawn Weimar, RN

We have heard the adage: “The definition of insanity is repeating the same mistakes but expecting a different result.” …

Report

An Analysis of Real Price Effects Resulting from Charge Setting Practices in the U.S. Hospital Sector

With Richard Fuller, MS

Published by the JKTG Foundation for Health and Policy, 2018,  by Richard Fuller, MS In this issue paper we focus…

3M Commentary

Introducing competition and price transparency into the Medicare payment system

By Richard Fuller, MS

Would an Amazon-like price shopping experience for individual healthcare services help control healthcare costs? Price transparency is frequently cited as…

3M Commentary

Controlling the cost of pharmaceuticals through the EAPG payment system

By Norbert Goldfield, MD, Richard Fuller, MS

In a recent blog we made the case for quantifying the net effect of drugs upon health expenditures so as…

3M Commentary

Integrating Sociodemographic Factors into Risk Adjustment: Important Considerations for NQF’s “Robust Trial Period”

By Norbert Goldfield, MD, Richard Fuller, MS

Why is it necessary that risk adjustment incorporate sociodemographic factors for my diabetic schizophrenic patients who have unstable housing? Healthcare…

3M Commentary

The Real Impact of DRGs: Meaningful Data that Changed Hospital Management

By Richard Averill, MS

A recent blog by François de Brantes, executive director of HCI3, titled “Letting the Facts Get in the Way

3M Commentary

Readmission Perspectives Part Two: Warranty Rewards for Improved Readmission Rates

By Norbert Goldfield, MD, Richard Fuller, MS

Two separate articles on readmission policy by Drs. Ashish Jha and Robert Berenson, recently published in the New England Journal…